Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cross Timbers Royalty Royalty Trust | CRT | Sep 19, 2024 | 9.30 | +0.54 |
CrossAmerica Partners LP Unit | CAPL | Sep 19, 2024 | 20.97 | -1.13 |
CrossFirst Bankshares | CFB | Sep 19, 2024 | 17.65 | +1.79 |
CrowdStrike A | CRWD | Sep 19, 2024 | 277.38 | +3.84 |
Crown Castle | CCI | Sep 19, 2024 | 115.17 | -2.22 |
Crown Crafts | CRWS | Sep 19, 2024 | 4.78 | +0.42 |
Crown ElectroKinetics | CRKN | Sep 19, 2024 | 1.24 | -1.59 |
Crown Holdings | CCK | Sep 19, 2024 | 94.43 | +1.40 |
Crown LNG | CGBS | Sep 19, 2024 | 0.28 | 0.00 |
Cryo-Cell International | CCEL | Sep 19, 2024 | 6.17 | -1.28 |
CryoPort | CYRX | Sep 19, 2024 | 8.73 | +7.51 |
CS Disco | LAW | Sep 19, 2024 | 6.03 | +3.61 |
CSG Systems International | CSGS | Sep 19, 2024 | 48.42 | +1.19 |
CSP | CSPI | Sep 19, 2024 | 12.48 | +1.79 |
CSW Industrials | CSWI | Sep 19, 2024 | 359.45 | +1.99 |
CSX | CSX | Sep 19, 2024 | 34.80 | +2.20 |
CTO Realty Growth | CTO | Sep 19, 2024 | 19.44 | +0.67 |
CTO Realty Growth A Pref | CTO-A | Sep 19, 2024 | 24.11 | +2.16 |
CTS | CTS | Sep 19, 2024 | 48.57 | +3.27 |
CubeSmart | CUBE | Sep 19, 2024 | 54.08 | +0.15 |
Cue Biopharma | CUE | Sep 19, 2024 | 0.56 | +2.04 |
Cullen Frost Bankers B Pref | CFR-B | Sep 19, 2024 | 21.72 | +0.56 |
Cullen/Frost Bankers | CFR | Sep 19, 2024 | 115.56 | +3.37 |
Cullinan Therapeutics | CGEM | Sep 19, 2024 | 17.94 | +4.12 |
Cullman Bancorp | CULL | Sep 19, 2024 | 9.71 | 0.00 |
Culp | CULP | Sep 19, 2024 | 6.35 | +5.31 |
Cumberland Pharmaceuticals | CPIX | Sep 19, 2024 | 1.28 | +2.40 |
Cummins | CMI | Sep 19, 2024 | 309.14 | +2.82 |
Cumulus Media A | CMLS | Sep 19, 2024 | 1.49 | +0.68 |
Curevac N.V. | CVAC | Sep 19, 2024 | 3.29 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.